Zdrowie i gospodarka · 12/06/2014

FDA Releases Draft Guidance for Industry on Abbreviated New Drug Application Submissions

The US Food and Drug Administration (FDA) has published a draft guidance document to help pharmaceutical companies prepare high-quality abbreviated new drug applications (ANDAs) for FDA review, outlining statutory and regulatory requirements, and providing recommendations on content and format.